New epilepsy drug candidate takes first step in human safety trial
Knowledge-focused
Recruiting now
This early-stage study tests a new medicine called ABS-1230 in 74 healthy adults to see if it is safe and how the body processes it. The drug is being developed for a rare form of epilepsy (KCNT1-related epilepsy). Participants receive either the drug or a placebo, and researcher…
Phase: PHASE1 • Sponsor: Actio Biosciences, Inc. • Aim: Knowledge-focused
Last updated May 03, 2026 22:37 UTC